IFF Launches New Probiotic Brand for Metabolic Health
The company’s new supplement strain aims to support metabolic health by producing GABA in the human gut.
Updated on Oct. 27, 2026 in Nutrition
Live Poll
Do you trust that probiotic supplements provide meaningful benefits for your metabolic health?
IFF has introduced GutABAlite, a new probiotic brand featuring the Levilactobacillus brevis LBR-6108 strain. This ingredient is designed for use in functional foods and supplements to help support metabolic health.
Why it matters
The product is intended to meet growing consumer demand for metabolic health solutions. By producing GABA in the gut, the strain offers a novel approach to managing metabolic markers.
A six-week clinical study indicated that participants experienced approximately 18% lower fasting insulin and 20% lower HOMA-IR levels. The study noted that these probiotic effects diminished once participants stopped taking the supplement.
The players
IFF
IFF is a multinational company specializing in the production of ingredients for the food, beverage, and supplement industries.
The details
The probiotic works by producing GABA and increasing short-chain fatty acids within the gut environment. It is formulated specifically for incorporation into various functional food and supplement applications.
Timeline
The clinical study on metabolic markers lasted for six weeks.
IFF will showcase the strain at SupplySide Global from October 28-30, 2026.
Health Landscape
Comparing the GutABAlite study to the ORION-10 statin trial provides a framework for how novel nutritional interventions are measured against standard pharmacological benchmarks in metabolic research. This study follows the established pattern of evaluating metabolic interventions against baseline markers to determine their clinical viability.
Consumers looking to integrate this probiotic into their health routine should note that the supplement's metabolic benefits appear to dissipate once usage is discontinued. As with all new dietary additions, it is advisable to discuss the inclusion of functional food ingredients with a healthcare provider.
The takeaway
Probiotic interventions represent an emerging area of research for metabolic regulation through the gut microbiome. Individuals interested in this approach should monitor long-term clinical data to understand the sustainability of these metabolic improvements over extended periods.
What happens next
IFF will present the GutABAlite strain to industry professionals at the SupplySide Global event held from October 28-30, 2026.
Further reading
Learn more about the latest innovations in diet and wellness in our Nutrition section.
Source note: This article includes information reported by Nutritioninsight.
Live Poll
Do you trust that probiotic supplements provide meaningful benefits for your metabolic health?
